Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elyse Rafal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Dermatological Treatment|November 23, 2011
A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acneRobert T Brodell, Bethanee J Schlosser, Elyse Rafal, et al.
Cutis|October 20, 2007
A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adultsRichard Berger, Alicia Barba, Alan Fleischer, et al.
Dermatology and Therapy|October 15, 2023
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
Dermatology and Therapy|January 12, 2024
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2010
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimenDavid Pariser, Alicia Bucko, Richard Fried, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Dermatological Treatment|November 23, 2011
A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acneRobert T Brodell, Bethanee J Schlosser, Elyse Rafal, et al.
Cutis|October 20, 2007
A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adultsRichard Berger, Alicia Barba, Alan Fleischer, et al.
Dermatology and Therapy|October 15, 2023
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
Dermatology and Therapy|January 12, 2024
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled StudyStephen Schleicher, Angela Moore, Elyse Rafal, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2010
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimenDavid Pariser, Alicia Bucko, Richard Fried, et al.
Pageof 1